Crinetics Pharmaceuticals Inc (CRNX)
57.53
+1.46
(+2.60%)
USD |
NASDAQ |
Nov 21, 13:25
Crinetics Pharmaceuticals Price: 57.53 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 55.33 | 56.43 | 54.64 | 56.07 | 487234.0 |
Nov 19, 2024 | 53.15 | 55.21 | 53.15 | 55.17 | 604331.0 |
Nov 18, 2024 | 54.35 | 55.05 | 52.84 | 53.70 | 769960.0 |
Nov 15, 2024 | 60.13 | 60.15 | 54.42 | 54.72 | 908877.0 |
Nov 14, 2024 | 58.28 | 62.53 | 58.17 | 59.66 | 856656.0 |
Nov 13, 2024 | 60.00 | 61.16 | 58.50 | 58.92 | 1.141M |
Nov 12, 2024 | 59.99 | 60.48 | 58.20 | 58.78 | 935065.0 |
Nov 11, 2024 | 61.88 | 62.00 | 59.95 | 60.01 | 596998.0 |
Nov 08, 2024 | 59.60 | 60.93 | 58.98 | 60.69 | 573323.0 |
Nov 07, 2024 | 59.11 | 60.17 | 58.66 | 59.81 | 678997.0 |
Nov 06, 2024 | 60.02 | 60.90 | 58.58 | 59.16 | 1.042M |
Nov 05, 2024 | 56.49 | 57.88 | 55.28 | 57.81 | 326981.0 |
Nov 04, 2024 | 56.17 | 58.00 | 55.21 | 56.82 | 437940.0 |
Nov 01, 2024 | 56.50 | 57.81 | 56.19 | 56.69 | 357010.0 |
Oct 31, 2024 | 55.36 | 56.54 | 54.32 | 55.96 | 545550.0 |
Oct 30, 2024 | 55.91 | 56.96 | 55.43 | 55.76 | 389240.0 |
Oct 29, 2024 | 56.84 | 57.24 | 56.12 | 56.26 | 462478.0 |
Oct 28, 2024 | 58.64 | 59.67 | 56.82 | 57.15 | 545028.0 |
Oct 25, 2024 | 59.22 | 59.32 | 57.86 | 57.96 | 401292.0 |
Oct 24, 2024 | 58.50 | 59.39 | 58.30 | 58.74 | 398312.0 |
Oct 23, 2024 | 59.53 | 60.00 | 57.54 | 58.40 | 570148.0 |
Oct 22, 2024 | 58.49 | 60.04 | 58.26 | 59.61 | 1.101M |
Oct 21, 2024 | 58.61 | 58.88 | 57.47 | 58.70 | 837173.0 |
Oct 18, 2024 | 58.91 | 59.80 | 58.40 | 59.09 | 510476.0 |
Oct 17, 2024 | 58.81 | 59.68 | 57.99 | 58.92 | 850176.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
11.52
Minimum
Mar 16 2020
60.69
Maximum
Nov 08 2024
24.64
Average
19.73
Median
Jul 14 2021
Price Benchmarks
Clearside Biomedical Inc | 1.05 |
Biomea Fusion Inc | 6.43 |
NovaBay Pharmaceuticals Inc | 0.68 |
Palatin Technologies Inc | 0.9142 |
iBio Inc | 2.31 |
Price Related Metrics
PEG Ratio | -1.403 |
Price to Book Value | 6.405 |
Earnings Yield | -6.48% |
Market Cap | 5.335B |
PEGY Ratio | -1.403 |